Not checkedNot checked for notices yet.
APOE gene polymorphism in long-lived individuals from a central China population
Guodong Liu, Xiang Liu, Pulin Yu and 6 more
Scientific Reports · 2017
doi:10.1038/s41598-017-03227-5 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Previous studies from European and East Asian cohorts reported conflicting results over whether and how the frequencies of the three common alleles, ε 2, ε 3 and ε 4, of the apolioprotein E gene (APOE) , in long-lived individuals differ from those in younger age groups. This study was the first to analyse these frequencies of long-lived individuals from central China. Genotyping of APOE alleles and genotypes was carried out in 70 long-lived individuals and 204 younger controls. No difference in the frequency of any APOE allele or genotype was found between the long-lived participants and their younger controls, but the long-lived group seemed to have a higher ε 4 frequency (15.71%) than the 24–50 and 51–75 age groups (10.2% and 11.32%, P > 0.05). Notably, when compared with two other Chinese studies, the central China long-lived group had a higher ε 4 frequency than its southern and eastern China counterparts (15.71% vs . 2.82% and 2.54%, P < 0.05). It is not clear to what extent population substructure or lifestyles contributed to these divergent findings. A clear understanding of the contribution of APOE polymorphisms to longevity in the Han Chinese population may be achieved only through large scale studies with participants from well-defined regional clusters.
Abstract licence: CC BY-NC-ND
References33
- 28.
- 32.
- 33.
30 more references, whose wording the paper’s licence keeps private.
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.